
Clidnex-300 Capsules by Qonexa Lifecare Pvt. Ltd. contain Clindamycin Hydrochloride 300 mg, a lincosamide antibiotic prescribed for the treatment of certain bacterial infections caused by susceptible microorganisms.
Clindamycin works by inhibiting bacterial protein synthesis, helping stop the growth of infection-causing bacteria. It is active against certain Gram-positive bacteria and anaerobic microorganisms.
Clidnex-300 Capsules may be prescribed for skin and soft tissue infections, dental infections, certain respiratory tract infections, bone and joint infections, and selected anaerobic bacterial infections when clinically appropriate.
The medicine should be taken strictly according to a registered medical practitioner's prescription. Treatment duration depends on the infection, bacterial susceptibility and the patient's medical condition. Patients should promptly report severe or persistent diarrhea during or after treatment.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Qonexa Lifecare Pvt. Ltd. is a WHO-GMP certified pharmaceutical company based in Panchkula, Haryana, India. The company specializes in PCD (Propaganda Cum Distribution) pharma franchises and third-party/contract manufacturing services.
Key Details & Offerings
• Headquarters: Panchkula, Haryana
• Certifications: WHO-GMP compliant manufacturing and quality assurance standards
• Product Portfolio: Includes tablets, capsules, syrups, dry syrups, softgel capsules, injections, ointments, lotions, and an ayurvedic range.
• Business Model:
• District-wise monopoly rights for franchise partners
• Third-party and contract manufacturing for pharmaceutical and nutraceutical products
• Marketing and promotional support for distributors
• Contact Number: +91-8218719106
• Official Website: Qonexa Lifecare.